Vaxart Appoints Karen J. Wilson to its Board of Directors

...Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced the appointment of Karen J. Wilson to its B...
Read Full Article